By 2016, we have committed to end the practice of making payments to healthcare professionals (HCPs) to speak on our behalf about our medicines or vaccines to audiences who can prescribe or who can influence prescribing.
We will also end the practice of providing direct financial support for individual HCPs to attend medical conferences.
In the intervening period, we will continue to disclose any payments we do make to HCPs for speaking on our behalf about products or disease areas and for attending medical conferences. We are committed to publishing all other payments we make to HCPs as well.
This is in line with new guidance from the European Federation of Pharmaceutical Industry Association (EFPIA). Full details of the EFPIA Disclosure Code are available on the EFPIA website.
BE/COM/0012/15 Oct 2015